London-based Samphire Neuroscience raises €2.1 million to launch wearable that targets PMS and menstrual pain

Medtech startup Samphire Neuroscience secured €2.1 million in pre-seed funding to launch Nettle, their medical-grade neurostimulation wearable. The round saw contributions from notable venture firms with experience in medical devices and women’s health, including SOSV, FIRSTPICK, Afterwork, Seaside, Ayuh, and CVX Ventures. The round also saw participation from prominent angel investors such as Russell Buckley,…

The post London-based Samphire Neuroscience raises €2.1 million to launch wearable that targets PMS and menstrual pain appeared first on EU-Startups.